Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
24%
ALSO IN BBP
BBP
65
HOLDINGS
33%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 4.0% | 3.2% | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% | 3.0% | 3.0% |
|
BLUEPRINT MEDICINES CORP. | 3.8% | 2.3% | 2.3% |
|
IONIS PHARMACEUTICALS, INC. | 2.1% | 2.7% | 2.1% |
|
GILEAD SCIENCES INC | 1.9% | 2.1% | 1.9% |
WDNA Overweight Relative to BBP
|
NATERA INC | 4.4% |
 |
NOVOZYMES A/S-B SHARES | 3.2% |
|
STOKE THERAPEUTICS, INC. | 2.3% |
|
ELI LILLY & CO | 2.3% |
|
TWIST BIOSCIENCE CORP. | 2.2% |
|
VERACYTE INC | 2.1% |
 |
NOVARTIS AG | 1.9% |
|
VERICEL CORPORATION | 1.8% |
|
LABCORP HOLDINGS | 1.7% |
|
CORTEVA INC | 1.6% |
WDNA Underweight Relative to BBP
|
INSMED INC | -3.3% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
HALOZYME THERAPEUTICS INC | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |